FTNT vs IMRX · P/E 56, rev $6.80B vs $124.2M cap
Fortinet Inc (FTNT) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the FTNT and IMRX stock pages for the full models.
Not investment advice.